The Searle Company Competitors and Similar CompaniesClear all

The Searle Company's competitors and similar companies include Biohaven Pharmaceutical, Bio Farma, CSL and Shandong Saito Biotechnology.

	The Searle Company The Searle Company is a pharmaceutical company.	Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.	Bio Farma Bio Farma is a manufacturer of vaccines.	CSL CSL is a biotech company providing life-saving medicines.	Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
Founding Date	Founding Date 1965	Founding Date 2014	Founding Date 1890	Founding Date 1916	Founding Date 2010
Type	Type Private	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development
Locations	Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK	Locations New Haven, US HQ	Locations ID HQ	Locations Parkville, AU HQ King Of Prussia, US	Locations Heze, CN HQ
Employees	Employees 2,3511% increase	Employees 4271% decrease	Employees 1,2341% increase	Employees 32,698	Employees 1,200
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 95.1 b	Valuation ($) 708.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $14.7b (FY, 2024)	Revenue (est.) ¥1.2b (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $6.2b (FY, 2024)	Cost of goods ¥994.2m (FY, 2023)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $8.6b (FY, 2024)	Gross profit ¥271.8m (FY, 2023)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income $2.7b (FY, 2024)	Net income ¥48.5m (FY, 2023)